Journal article 1217 views 113 downloads
Early Discontinuation of P2Y12 Antagonists and Adverse Clinical Events Post–Percutaneous Coronary Intervention: A Hospital and Primary Care Linked Cohort
Journal of the American Heart Association, Volume: 8, Issue: 21, Start page: A74
Swansea University Authors: Daniel Harris, Arron Lacey , Ashley Akbari , Daniel Obaid , Michael Gravenor , Julian Halcox
-
PDF | Version of Record
Released under the terms of a Creative Commons Attribution-NonCommercial License (CC-BY-NC).
Download (1.24MB)
DOI (Published version): 10.1161/jaha.119.012812
Abstract
Early Discontinuation of P2Y12 Antagonists and Adverse Clinical Events Post–Percutaneous Coronary Intervention: A Hospital and Primary Care Linked Cohort
Published in: | Journal of the American Heart Association |
---|---|
ISSN: | 0735-1097 2047-9980 |
Published: |
Ovid Technologies (Wolters Kluwer Health)
2019
|
Online Access: |
Check full text
|
URI: | https://cronfa.swan.ac.uk/Record/cronfa40257 |
first_indexed |
2018-05-18T03:59:24Z |
---|---|
last_indexed |
2023-02-15T03:49:35Z |
id |
cronfa40257 |
recordtype |
SURis |
fullrecord |
<?xml version="1.0"?><rfc1807><datestamp>2023-02-14T15:37:46.9557805</datestamp><bib-version>v2</bib-version><id>40257</id><entry>2018-05-17</entry><title>Early Discontinuation of P2Y12 Antagonists and Adverse Clinical Events Post–Percutaneous Coronary Intervention: A Hospital and Primary Care Linked Cohort</title><swanseaauthors><author><sid>e60c9c73b645f0e8033ae26fa8e634b8</sid><firstname>Daniel</firstname><surname>Harris</surname><name>Daniel Harris</name><active>true</active><ethesisStudent>false</ethesisStudent></author><author><sid>b69d245574e754d2637cc9e76379fe11</sid><ORCID>0000-0001-7983-8073</ORCID><firstname>Arron</firstname><surname>Lacey</surname><name>Arron Lacey</name><active>true</active><ethesisStudent>false</ethesisStudent></author><author><sid>aa1b025ec0243f708bb5eb0a93d6fb52</sid><ORCID>0000-0003-0814-0801</ORCID><firstname>Ashley</firstname><surname>Akbari</surname><name>Ashley Akbari</name><active>true</active><ethesisStudent>false</ethesisStudent></author><author><sid>1cb4b49224d4f3f2b546ed0f39e13ea8</sid><ORCID>0000-0002-3891-1403</ORCID><firstname>Daniel</firstname><surname>Obaid</surname><name>Daniel Obaid</name><active>true</active><ethesisStudent>false</ethesisStudent></author><author><sid>70a544476ce62ba78502ce463c2500d6</sid><ORCID>0000-0003-0710-0947</ORCID><firstname>Michael</firstname><surname>Gravenor</surname><name>Michael Gravenor</name><active>true</active><ethesisStudent>false</ethesisStudent></author><author><sid>3676f695eeda169d0f8c618adf27c04b</sid><ORCID>0000-0001-6926-2947</ORCID><firstname>Julian</firstname><surname>Halcox</surname><name>Julian Halcox</name><active>true</active><ethesisStudent>false</ethesisStudent></author></swanseaauthors><date>2018-05-17</date><deptcode>MEDS</deptcode><abstract/><type>Journal Article</type><journal>Journal of the American Heart Association</journal><volume>8</volume><journalNumber>21</journalNumber><paginationStart>A74</paginationStart><paginationEnd/><publisher>Ovid Technologies (Wolters Kluwer Health)</publisher><placeOfPublication/><isbnPrint/><isbnElectronic/><issnPrint>0735-1097</issnPrint><issnElectronic>2047-9980</issnElectronic><keywords>Clopidogrel, myocardial infarction, post–percutaneous coronary intervention,</keywords><publishedDay>5</publishedDay><publishedMonth>11</publishedMonth><publishedYear>2019</publishedYear><publishedDate>2019-11-05</publishedDate><doi>10.1161/jaha.119.012812</doi><url/><notes/><college>COLLEGE NANME</college><department>Medical School</department><CollegeCode>COLLEGE CODE</CollegeCode><DepartmentCode>MEDS</DepartmentCode><institution>Swansea University</institution><apcterm/><funders/><projectreference/><lastEdited>2023-02-14T15:37:46.9557805</lastEdited><Created>2018-05-17T22:19:00.2679409</Created><path><level id="1">Faculty of Medicine, Health and Life Sciences</level><level id="2">Swansea University Medical School - Health Data Science</level></path><authors><author><firstname>Daniel</firstname><surname>Harris</surname><order>1</order></author><author><firstname>Arron</firstname><surname>Lacey</surname><orcid>0000-0001-7983-8073</orcid><order>2</order></author><author><firstname>Ashley</firstname><surname>Akbari</surname><orcid>0000-0003-0814-0801</orcid><order>3</order></author><author><firstname>Daniel</firstname><surname>Obaid</surname><orcid>0000-0002-3891-1403</orcid><order>4</order></author><author><firstname>Dave A.</firstname><surname>Smith</surname><order>5</order></author><author><firstname>Geraint H.</firstname><surname>Jenkins</surname><order>6</order></author><author><firstname>James P.</firstname><surname>Barry</surname><order>7</order></author><author><firstname>Michael</firstname><surname>Gravenor</surname><orcid>0000-0003-0710-0947</orcid><order>8</order></author><author><firstname>Julian</firstname><surname>Halcox</surname><orcid>0000-0001-6926-2947</orcid><order>9</order></author></authors><documents><document><filename>40257__15934__17174f9e03db40eab094b6116d27acd9.pdf</filename><originalFilename>40257.pdf</originalFilename><uploaded>2019-11-21T14:33:42.7897644</uploaded><type>Output</type><contentLength>1299835</contentLength><contentType>application/pdf</contentType><version>Version of Record</version><cronfaStatus>true</cronfaStatus><documentNotes>Released under the terms of a Creative Commons Attribution-NonCommercial License (CC-BY-NC).</documentNotes><copyrightCorrect>true</copyrightCorrect></document></documents><OutputDurs/></rfc1807> |
spelling |
2023-02-14T15:37:46.9557805 v2 40257 2018-05-17 Early Discontinuation of P2Y12 Antagonists and Adverse Clinical Events Post–Percutaneous Coronary Intervention: A Hospital and Primary Care Linked Cohort e60c9c73b645f0e8033ae26fa8e634b8 Daniel Harris Daniel Harris true false b69d245574e754d2637cc9e76379fe11 0000-0001-7983-8073 Arron Lacey Arron Lacey true false aa1b025ec0243f708bb5eb0a93d6fb52 0000-0003-0814-0801 Ashley Akbari Ashley Akbari true false 1cb4b49224d4f3f2b546ed0f39e13ea8 0000-0002-3891-1403 Daniel Obaid Daniel Obaid true false 70a544476ce62ba78502ce463c2500d6 0000-0003-0710-0947 Michael Gravenor Michael Gravenor true false 3676f695eeda169d0f8c618adf27c04b 0000-0001-6926-2947 Julian Halcox Julian Halcox true false 2018-05-17 MEDS Journal Article Journal of the American Heart Association 8 21 A74 Ovid Technologies (Wolters Kluwer Health) 0735-1097 2047-9980 Clopidogrel, myocardial infarction, post–percutaneous coronary intervention, 5 11 2019 2019-11-05 10.1161/jaha.119.012812 COLLEGE NANME Medical School COLLEGE CODE MEDS Swansea University 2023-02-14T15:37:46.9557805 2018-05-17T22:19:00.2679409 Faculty of Medicine, Health and Life Sciences Swansea University Medical School - Health Data Science Daniel Harris 1 Arron Lacey 0000-0001-7983-8073 2 Ashley Akbari 0000-0003-0814-0801 3 Daniel Obaid 0000-0002-3891-1403 4 Dave A. Smith 5 Geraint H. Jenkins 6 James P. Barry 7 Michael Gravenor 0000-0003-0710-0947 8 Julian Halcox 0000-0001-6926-2947 9 40257__15934__17174f9e03db40eab094b6116d27acd9.pdf 40257.pdf 2019-11-21T14:33:42.7897644 Output 1299835 application/pdf Version of Record true Released under the terms of a Creative Commons Attribution-NonCommercial License (CC-BY-NC). true |
title |
Early Discontinuation of P2Y12 Antagonists and Adverse Clinical Events Post–Percutaneous Coronary Intervention: A Hospital and Primary Care Linked Cohort |
spellingShingle |
Early Discontinuation of P2Y12 Antagonists and Adverse Clinical Events Post–Percutaneous Coronary Intervention: A Hospital and Primary Care Linked Cohort Daniel Harris Arron Lacey Ashley Akbari Daniel Obaid Michael Gravenor Julian Halcox |
title_short |
Early Discontinuation of P2Y12 Antagonists and Adverse Clinical Events Post–Percutaneous Coronary Intervention: A Hospital and Primary Care Linked Cohort |
title_full |
Early Discontinuation of P2Y12 Antagonists and Adverse Clinical Events Post–Percutaneous Coronary Intervention: A Hospital and Primary Care Linked Cohort |
title_fullStr |
Early Discontinuation of P2Y12 Antagonists and Adverse Clinical Events Post–Percutaneous Coronary Intervention: A Hospital and Primary Care Linked Cohort |
title_full_unstemmed |
Early Discontinuation of P2Y12 Antagonists and Adverse Clinical Events Post–Percutaneous Coronary Intervention: A Hospital and Primary Care Linked Cohort |
title_sort |
Early Discontinuation of P2Y12 Antagonists and Adverse Clinical Events Post–Percutaneous Coronary Intervention: A Hospital and Primary Care Linked Cohort |
author_id_str_mv |
e60c9c73b645f0e8033ae26fa8e634b8 b69d245574e754d2637cc9e76379fe11 aa1b025ec0243f708bb5eb0a93d6fb52 1cb4b49224d4f3f2b546ed0f39e13ea8 70a544476ce62ba78502ce463c2500d6 3676f695eeda169d0f8c618adf27c04b |
author_id_fullname_str_mv |
e60c9c73b645f0e8033ae26fa8e634b8_***_Daniel Harris b69d245574e754d2637cc9e76379fe11_***_Arron Lacey aa1b025ec0243f708bb5eb0a93d6fb52_***_Ashley Akbari 1cb4b49224d4f3f2b546ed0f39e13ea8_***_Daniel Obaid 70a544476ce62ba78502ce463c2500d6_***_Michael Gravenor 3676f695eeda169d0f8c618adf27c04b_***_Julian Halcox |
author |
Daniel Harris Arron Lacey Ashley Akbari Daniel Obaid Michael Gravenor Julian Halcox |
author2 |
Daniel Harris Arron Lacey Ashley Akbari Daniel Obaid Dave A. Smith Geraint H. Jenkins James P. Barry Michael Gravenor Julian Halcox |
format |
Journal article |
container_title |
Journal of the American Heart Association |
container_volume |
8 |
container_issue |
21 |
container_start_page |
A74 |
publishDate |
2019 |
institution |
Swansea University |
issn |
0735-1097 2047-9980 |
doi_str_mv |
10.1161/jaha.119.012812 |
publisher |
Ovid Technologies (Wolters Kluwer Health) |
college_str |
Faculty of Medicine, Health and Life Sciences |
hierarchytype |
|
hierarchy_top_id |
facultyofmedicinehealthandlifesciences |
hierarchy_top_title |
Faculty of Medicine, Health and Life Sciences |
hierarchy_parent_id |
facultyofmedicinehealthandlifesciences |
hierarchy_parent_title |
Faculty of Medicine, Health and Life Sciences |
department_str |
Swansea University Medical School - Health Data Science{{{_:::_}}}Faculty of Medicine, Health and Life Sciences{{{_:::_}}}Swansea University Medical School - Health Data Science |
document_store_str |
1 |
active_str |
0 |
published_date |
2019-11-05T19:25:10Z |
_version_ |
1821344122376552448 |
score |
11.04748 |